These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 2411797)
1. Hyporesponsiveness to augmentation of murine natural killer cell activity in different anatomical compartments by multiple injections of various immunomodulators including recombinant interferons and interleukin 2. Talmadge JE; Herberman RB; Chirigos MA; Maluish AE; Schneider MA; Adams JS; Philips H; Thurman GB; Varesio L; Long C J Immunol; 1985 Oct; 135(4):2483-91. PubMed ID: 2411797 [TBL] [Abstract][Full Text] [Related]
2. Development of hyporesponsiveness to augmentation of natural killer cell activity after multiple doses of maleic anhydride divinyl ether: association with decreased numbers of large granular lymphocytes. Saito T; Welker RD; Fukui H; Herberman RB; Chirigos MA Cell Immunol; 1985 Feb; 90(2):577-89. PubMed ID: 3871375 [TBL] [Abstract][Full Text] [Related]
3. Development of hyporesponsiveness of natural killer cells to augmentation of activity after multiple treatments with biological response modifiers. Saito T; Ruffman R; Welker RD; Herberman RB; Chirigos MA Cancer Immunol Immunother; 1985; 19(2):130-5. PubMed ID: 3845849 [TBL] [Abstract][Full Text] [Related]
4. Augmentation of mouse liver-associated natural killer activity by biologic response modifiers occurs largely via rapid recruitment of large granular lymphocytes from the bone marrow. Wiltrout RH; Pilaro AM; Gruys ME; Talmadge JE; Longo DL; Ortaldo JR; Reynolds CW J Immunol; 1989 Jul; 143(1):372-8. PubMed ID: 2732472 [TBL] [Abstract][Full Text] [Related]
5. Augmentation of organ-associated natural killer activity by biological response modifiers. Isolation and characterization of large granular lymphocytes from the liver. Wiltrout RH; Mathieson BJ; Talmadge JE; Reynolds CW; Zhang SR; Herberman RB; Ortaldo JR J Exp Med; 1984 Nov; 160(5):1431-49. PubMed ID: 6491601 [TBL] [Abstract][Full Text] [Related]
6. Augmentation of NK activity and/or macrophage-mediated cytotoxicity in the liver by biological response modifiers including human recombinant interleukin 2. Zhang SR; Salup RR; Urias PE; Twilley TA; Talmadge JE; Herberman RB; Wiltrout RH Cancer Immunol Immunother; 1986; 21(1):19-25. PubMed ID: 3484675 [TBL] [Abstract][Full Text] [Related]
7. Role of organ-associated NK cells in decreased formation of experimental metastases in lung and liver. Wiltrout RH; Herberman RB; Zhang SR; Chirigos MA; Ortaldo JR; Green KM; Talmadge JE J Immunol; 1985 Jun; 134(6):4267-75. PubMed ID: 3989307 [TBL] [Abstract][Full Text] [Related]
8. Augmentation of natural cell activity in tumor-bearing and normal mice by MVE-2. Budzynski W; Chirigos M; Gruys E Cancer Immunol Immunother; 1987; 24(3):253-8. PubMed ID: 3594488 [TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of natural killer function in lung, spleen, and peripheral blood lymphocytes: evidence of differential characteristics. Lauzon W; Yang H; Lemaire I Reg Immunol; 1990-1991; 3(3):145-50. PubMed ID: 2129104 [TBL] [Abstract][Full Text] [Related]
10. Protection against murine cytomegalovirus infection in aged mice and mice with severe combined immunodeficiency disease with the biological response modifiers polyribosinic-polycytidylic acid stabilized with L-lysine and carboxymethylcellulose, maleic anhydride divinyl ether and colony stimulating factor 1. Kunder SC; Wu L; Morahan PS Antiviral Res; 1993 Jul; 21(3):233-45. PubMed ID: 7692814 [TBL] [Abstract][Full Text] [Related]
11. Interaction of recombinant interferons with recombinant interleukin-2: differential effects on natural killer cell activity and interleukin-2-activated killer cells. Brunda MJ; Tarnowski D; Davatelis V Int J Cancer; 1986 May; 37(5):787-93. PubMed ID: 2422129 [TBL] [Abstract][Full Text] [Related]
12. Effects of biological response modifiers on lung natural killer activity. Lauzon W; Lemaire I Immunopharmacol Immunotoxicol; 1991; 13(3):237-50. PubMed ID: 1719060 [TBL] [Abstract][Full Text] [Related]
14. Bimodal effects of MVE-2 on cytotoxic activity of natural killer cell and macrophage tumoricidal activities. Piccoli M; Saito T; Chirigos MA Int J Immunopharmacol; 1984; 6(6):569-76. PubMed ID: 6511143 [TBL] [Abstract][Full Text] [Related]
15. Regulation of natural killer cell activation: implementation for the control of tumor metastasis. Hanna N Nat Immun Cell Growth Regul; 1983-1984; 3(1):22-33. PubMed ID: 6235447 [TBL] [Abstract][Full Text] [Related]
16. Antiviral activity of biological response modifiers in a murine model of AIDS. Requirement for augmentation of natural killer cell activity and synergy with oral AZT. Black PL; McKinnon KM; Wooden SL; Ussery MA Int J Immunopharmacol; 1996 Nov; 18(11):633-50. PubMed ID: 9089007 [TBL] [Abstract][Full Text] [Related]
17. Augmentation of natural killer activity, induction of IFN and development tumor immunity during the successful treatment of established murine renal cancer using flavone acetic acid and IL-2. Hornung RL; Back TC; Zaharko DS; Urba WJ; Longo DL; Wiltrout RH J Immunol; 1988 Nov; 141(10):3671-9. PubMed ID: 2460546 [TBL] [Abstract][Full Text] [Related]
18. Differences in murine gut-associated lymphoid tissues in generating broadly nonspecific cytotoxic cells in response to interferon alpha A/D and interleukin 2. Chikkala NF; Gautam SC Cell Immunol; 1991 Jul; 135(2):418-30. PubMed ID: 2036676 [TBL] [Abstract][Full Text] [Related]
19. Studies on the mechanism of natural killer cytotoxicity. III. Activation of NK cells by interferon augments the lytic activity of released natural killer cytotoxic factors (NKCF). Wright SC; Bonavida B J Immunol; 1983 Jun; 130(6):2960-4. PubMed ID: 6189908 [TBL] [Abstract][Full Text] [Related]